These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 29381619)
1. Intralesional Bleomycin Injection for Propranolol-Resistant Hemangiomas. Chang L; Chen H; Yang X; Jin Y; Ma G; Lin X J Craniofac Surg; 2018 Mar; 29(2):e128-e130. PubMed ID: 29381619 [TBL] [Abstract][Full Text] [Related]
2. Intralesional bleomycin for the treatment of periocular capillary hemangiomas. Smit DP; Meyer D Indian J Ophthalmol; 2012 Jul; 60(4):326-8. PubMed ID: 22824608 [TBL] [Abstract][Full Text] [Related]
3. Intralesional bleomycin injection for periocular capillary hemangiomas. Gupta VP; Gupta P Indian J Ophthalmol; 2013 Jul; 61(7):367-8. PubMed ID: 23896454 [No Abstract] [Full Text] [Related]
4. Eighteen cases of soft tissue atrophy after intralesional bleomycin a5 injections for the treatment of infantile hemangiomas: a long-term follow-up. Qiu Y; Lin X; Ma G; Chang L; Jin Y; Chen H; Hu X Pediatr Dermatol; 2015; 32(2):188-91. PubMed ID: 25640925 [TBL] [Abstract][Full Text] [Related]
5. Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol. Vassallo P; Forte R; Di Mezza A; Magli A Am J Ophthalmol; 2013 Jan; 155(1):165-170.e2. PubMed ID: 22967870 [TBL] [Abstract][Full Text] [Related]
6. Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol. Rotter A; Samorano LP; de Oliveira Labinas GH; Alvarenga JG; Rivitti-Machado MC; Bouer M; Santos PC; Silvestre DA; de Oliveira ZN Int J Dermatol; 2017 Feb; 56(2):190-194. PubMed ID: 27813086 [TBL] [Abstract][Full Text] [Related]
7. How to use bleomycin A5 for infantile maxillofacial haemangiomas: clinical evaluation of 82 consecutive cases. Luo Q; Zhao F J Craniomaxillofac Surg; 2011 Oct; 39(7):482-6. PubMed ID: 20675147 [TBL] [Abstract][Full Text] [Related]
8. A new treatment pathway for propranolol use in infantile haemangiomas. May JE; Liew SH J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):e91-2. PubMed ID: 24268691 [No Abstract] [Full Text] [Related]
9. A new treatment with bleomycin for complicated cutaneous hemangioma in children. Sarihan H; Mocan H; Yildiz K; Abes M; Akyazici R Eur J Pediatr Surg; 1997 Jun; 7(3):158-62. PubMed ID: 9241503 [TBL] [Abstract][Full Text] [Related]
10. Infantile hemangioma: Efficacy of low-dose propranolol and of intralesional bleomycin injection for propranolol non-response. Düzenli Kar Y; Özdemir ZC; Acu B; Bör Ö Pediatr Int; 2019 May; 61(5):459-464. PubMed ID: 30861274 [TBL] [Abstract][Full Text] [Related]
11. Failure of intralesional propranolol in infantile hemangiomas. Torres-Pradilla M; Baselga E Pediatr Dermatol; 2014; 31(2):156-8. PubMed ID: 24000875 [TBL] [Abstract][Full Text] [Related]
12. Treatment with propranolol for infantile hemangiomas: single-center experience. Turhan AB; Bör Ö; Özdemir ZC J Cosmet Dermatol; 2016 Sep; 15(3):296-302. PubMed ID: 27061310 [TBL] [Abstract][Full Text] [Related]
13. Individualized Treatment for Infantile Hemangioma. Xu MN; Zhang M; Xu Y; Wang M; Yuan SM J Craniofac Surg; 2018 Oct; 29(7):1876-1879. PubMed ID: 30052610 [TBL] [Abstract][Full Text] [Related]
14. Role of intralesional bleomycin and intralesional triamcinolone therapy in residual haemangioma following propranolol. Pandey V; Tiwari P; Sharma SP; Kumar R; Singh OP Int J Oral Maxillofac Surg; 2018 Jul; 47(7):908-912. PubMed ID: 29665992 [TBL] [Abstract][Full Text] [Related]
15. Comparison of efficacy of intralesional bleomycin and oral propanolol in management of hemangiomas. Thayal PK; Bhandari PS; Sarin YK Plast Reconstr Surg; 2012 Apr; 129(4):733e-735e. PubMed ID: 22456397 [No Abstract] [Full Text] [Related]
16. [Local injection of bleomycin A 5 in children with hemangiomas. Analysis of 210 cases]. Zheng QT Zhonghua Wai Ke Za Zhi; 1991 May; 29(5):290-1, 334. PubMed ID: 1717207 [TBL] [Abstract][Full Text] [Related]
17. Propranolol versus prednisone in the treatment of infantile hemangiomas: a retrospective comparative study. Bertrand J; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Powell J Pediatr Dermatol; 2011; 28(6):649-654. PubMed ID: 21995756 [TBL] [Abstract][Full Text] [Related]
18. [Subsequent therapy for infantile hemangiomas after discontinuation of oral propranolol]. Tai MZ; Liu XJ; Qin ZP; Ge CX; Li KL; Chen T Shanghai Kou Qiang Yi Xue; 2015 Dec; 24(6):716-20. PubMed ID: 27063125 [TBL] [Abstract][Full Text] [Related]
19. Consensus statement for the treatment of infantile haemangiomas with propranolol. Smithson SL; Rademaker M; Adams S; Bade S; Bekhor P; Davidson S; Dore A; Drummond C; Fischer G; Gin A; Grills C; Halbert A; Lokmic Z; McCahon E; Morgan VA; Murrell DF; Orchard D; Penington A; Purvis D; Relic J; Robertson S; Robinson AJ; Scardamaglia L; Su J; Tan S; Wargon O; Warren L; Wong LC; Zappala T; Phillips R Australas J Dermatol; 2017 May; 58(2):155-159. PubMed ID: 28251611 [TBL] [Abstract][Full Text] [Related]